Chronic treatment with anesthetic propofol improves cognitive function and attenuates caspase activation in both aged and Alzheimer's disease transgenic mice.

PubWeight™: 0.80‹?›

🔗 View Article (PMC 4071129)

Published in J Alzheimers Dis on January 01, 2014

Authors

Haijun Shao1,2, Yiying Zhang1, Yuanlin Dong1, Buwei Yu2, Weiming Xia3, Zhongcong Xie1

Author Affiliations

1: Geriatric Anesthesia Research Unit, Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA, USA.
2: Department of Anesthesiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P.R. China.
3: Department of Veterans Affairs, Medical Research and Development Service and Geriatric Research, Education and Clinical Center, Bedford, MA, USA.

Articles cited by this

Caspases: enemies within. Science (1998) 19.45

Alzheimer's disease. N Engl J Med (2010) 13.13

Mitochondrial membrane permeabilization in cell death. Physiol Rev (2007) 12.72

Regulation of cell death: the calcium-apoptosis link. Nat Rev Mol Cell Biol (2003) 9.07

Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease. N Engl J Med (2014) 6.67

Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease. N Engl J Med (2014) 6.50

Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease. Arch Neurol (2002) 4.42

Targeting mitochondria for cancer therapy. Nat Rev Drug Discov (2010) 4.07

Depletion of GGA3 stabilizes BACE and enhances beta-secretase activity. Neuron (2007) 3.98

Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic A beta peptide formation. Cell (1999) 3.58

Caspase signalling controls microglia activation and neurotoxicity. Nature (2011) 3.44

Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A (2009) 3.31

Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease. Neurobiol Dis (2006) 2.96

Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia. J Neurosci (1998) 2.55

The inhalation anesthetic isoflurane induces a vicious cycle of apoptosis and amyloid beta-protein accumulation. J Neurosci (2007) 2.42

Amyloid beta-induced neuronal hyperexcitability triggers progressive epilepsy. J Neurosci (2009) 2.33

Brain and behavior changes in 12-month-old Tg2576 and nontransgenic mice exposed to anesthetics. Neurobiol Aging (2007) 2.13

Selective anesthesia-induced neuroinflammation in developing mouse brain and cognitive impairment. Anesthesiology (2013) 1.93

The actions of propofol on inhibitory amino acid receptors of bovine adrenomedullary chromaffin cells and rodent central neurones. Br J Pharmacol (1991) 1.81

Immunohistochemical evidence for apoptosis in Alzheimer's disease. Neuroreport (1994) 1.81

Propofol enhances memory formation via an interaction with the endocannabinoid system. Anesthesiology (2011) 1.76

Anesthetics isoflurane and desflurane differently affect mitochondrial function, learning, and memory. Ann Neurol (2012) 1.76

Mitochondrial permeability transition in CNS trauma: cause or effect of neuronal cell death? J Neurosci Res (2004) 1.75

Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease. Evidence for apoptotic cell death. Am J Pathol (1999) 1.71

Alternative cleavage of Alzheimer-associated presenilins during apoptosis by a caspase-3 family protease. Science (1997) 1.66

The mitochondrial pathway of anesthetic isoflurane-induced apoptosis. J Biol Chem (2009) 1.64

Bilateral inhibition of gamma-aminobutyric acid type A receptor function within the basolateral amygdala blocked propofol-induced amnesia and activity-regulated cytoskeletal protein expression inhibition in the hippocampus. Anesthesiology (2008) 1.54

Caspase-3 is enriched in postsynaptic densities and increased in Alzheimer's disease. Am J Pathol (2008) 1.47

The role of apoptotic pathways in Alzheimer's disease neurodegeneration and cell death. Curr Alzheimer Res (2005) 1.33

Propofol neuroprotection in cerebral ischemia and its effects on low-molecular-weight antioxidants and skilled motor tasks. Anesthesiology (2004) 1.29

Symptomatic and nonamyloid/tau based pharmacologic treatment for Alzheimer disease. Cold Spring Harb Perspect Med (2012) 1.25

Propofol directly increases tau phosphorylation. PLoS One (2011) 1.25

Propofol neurotoxicity is mediated by p75 neurotrophin receptor activation. Anesthesiology (2012) 1.21

Sevoflurane anesthesia in pregnant mice induces neurotoxicity in fetal and offspring mice. Anesthesiology (2013) 1.16

Mitochondrial control of cell death induced by hyperosmotic stress. Apoptosis (2007) 1.15

Abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease. J Alzheimers Dis (2013) 1.11

Increased production of amyloid precursor protein provides a substrate for caspase-3 in dying motoneurons. J Neurosci (1998) 1.11

Bax protein expression is increased in Alzheimer's brain: correlations with DNA damage, Bcl-2 expression, and brain pathology. J Neuropathol Exp Neurol (1997) 1.09

Presenilins are processed by caspase-type proteases. J Biol Chem (1997) 1.08

Loss of functional GABA(A) receptors in the Alzheimer diseased brain. Proc Natl Acad Sci U S A (2012) 1.04

Propofol: neuroprotection in an in vitro model of traumatic brain injury. Crit Care (2009) 1.01

Caspase-mediated degeneration in Alzheimer's disease. Am J Pathol (2004) 1.00

Implications for treatment: GABAA receptors in aging, Down syndrome and Alzheimer's disease. J Neurochem (2011) 0.99

Caspases: a treatment target for neurodegenerative disease? Nat Med (1997) 0.98

Anesthetic propofol attenuates the isoflurane-induced caspase-3 activation and Aβ oligomerization. PLoS One (2011) 0.98

Biochemical and behavioral characterization of the double transgenic mouse model (APPswe/PS1dE9) of Alzheimer's disease. Neurosci Bull (2011) 0.98

Apoptotic promoters and inhibitors in Alzheimer's disease: Who wins out? Prog Neuropsychopharmacol Biol Psychiatry (2003) 0.95

Propofol anesthesia impairs the maturation and survival of adult-born hippocampal neurons. Anesthesiology (2013) 0.95

Neurosteroid and GABA-A receptor alterations in Alzheimer's disease, Parkinson's disease and multiple sclerosis. Neuroscience (2011) 0.92

Effect of propofol on memory in mice. Pharmacol Biochem Behav (1993) 0.91

Staurosporine-induced activation of caspase-3 is potentiated by presenilin 1 familial Alzheimer's disease mutations in human neuroglioma cells. J Neurochem (1999) 0.90

Propofol and midazolam inhibit conscious memory processes very soon after encoding: an event-related potential study of familiarity and recollection in volunteers. Anesthesiology (2009) 0.88

Contributions of mitochondrial alterations, resulting from bad genes and a hostile environment, to the pathogenesis of Alzheimer's disease. Int Rev Neurobiol (2002) 0.88

Pathological mechanisms in Huntington's disease and other polyglutamine expansion diseases. Essays Biochem (1998) 0.88

GABAA receptor beta 2 and beta 3 subunits mRNA in the hippocampal formation of aged human brain with Alzheimer-related neuropathology. Brain Res Mol Brain Res (1998) 0.86

Nefiracetam prevents propofol-induced anterograde and retrograde amnesia in the rodent without compromising quality of anesthesia. Anesthesiology (1998) 0.84

Propofol and magnesium attenuate isoflurane-induced caspase-3 activation via inhibiting mitochondrial permeability transition pore. Med Gas Res (2012) 0.82

Induction of partial epileptic seizures by flumazenil. Epilepsia (2000) 0.79

Flumazenil, a GABA antagonist, may improve features of Parkinson's disease. Mov Disord (2003) 0.78

The role of transcriptional and translational mechanisms in flumazenil-induced up-regulation of recombinant GABA(A) receptors. Neurosci Res (2008) 0.77